Key Findings:  Recent discoveries in cannabinoid-based pharmacology suggests a successful route of various types of cannabinoids to be employed in the treatment of neurodegeneration associated with Parkinson's, Alzheimer's, and Huntington's disease.
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  Spain
Year of Pub:  2021
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Receptors Studied:  CB1, CB2, GPCR 3, GPCR 6, GPCR 18, GPCR 55, PPARs